Vol 83, No 1 (2025)
Clinical vignette
Published online: 2024-10-03

open access

Page views 277
Article views/downloads 193
Get Citation

Connect on Social Media

Connect on Social Media

Endovascular treatment of superior vena cava thrombosis: A challenging case and an alternative technique

Duygu İnan1, Ali Nural2, Göksel Çinier1, Gönül Zeren2, İlhan İlker Avcı2, Can Yücel Karabay2
Pubmed: 39377631
Pol Heart J 2025;83(1):96-97.

Abstract

Not available

Article available in PDF format

View PDF Download PDF file

References

  1. Shenoy S, Shetty S, Lankala S, et al. Cardiovascular Oncologic Emergencies. Cardiology. 2017; 138(3): 147–158.
  2. Escalante CP. Causes and management of superior vena cava syndrome. Oncology. 1993; 7: 61–68.
  3. Rice TW, Rodriguez RM, Light RW. The superior vena cava syndrome: clinical characteristics and evolving etiology. Medicine (Baltimore). 2006; 85(1): 37–42.
  4. Charnsangavej C, Carrasco CH, Wallace S, et al. Stenosis of the vena cava: preliminary assessment of treatment with expandable metallic stents. Radiology. 1986; 161(2): 295–298.
  5. Chatziioannou A, Alexopoulos Th, Mourikis D, et al. Stent therapy for malignant superior vena cava syndrome: should be first line therapy or simple adjunct to radiotherapy. Eur J Radiol. 2003; 47(3): 247–250.